NCI, FDA Make Progress On Some Issues, Bu Differences Remain On Endpoints
In Brief: Waldmann, Fisher Win Top Miken Prizes Of $250,000 Each, Six Others Get $50,000
DCBD Board Votes down, Then Approves Organ Systems PA
NCAB Action On Diet FIT “Not Cavalier,” Chairman Korn Says
Why Shouldn’t Scientific Issues Be Discussed In Open Meetings? Editorial
Trending Stories
- Is it time to re-assess the practice and practicality of screening colonoscopy?
Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives - Michael Caputo appointed to President’s Cancer Panel
The cancer survivor and political operative says his appointment signals Trump’s interest in cancer, survivorship - Oncologist Rachna Shroff endows award to outlast her cancer diagnosis
“Because of my health, I have a profound desire to see this endowment come to fruition now” - KRAS pioneer and Stephenson Prize winner Frank McCormick aims to prevent all KRAS cancers with a pill
- From “default dead” to living the future of cancer care
As founding CEO of GitLab, I went “founder mode” on my osteosarcoma - Anthony Letai reflects on Year One as NCI Director: “The NCI is in business”









